Discovery, Development, and Partnering of Novel Retinal Neuroprotective Drug Candidates
Connexin Therapeutics is a new company aiming to discover novel compounds which protect retinal neurons under threat from glaucoma, diabetic retinopathy, and other ophthalmic conditions.
Connexin Therapeutics is raising Seed/Series A financing to execute on our highly efficient discovery program.
Connexin Therapeutics is raising Seed/Series A financing to execute on our highly efficient discovery program.